Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioInvent International AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioInvent International AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioInvent International AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioInvent and Transgene Enter into Co-Development Agreement 11
BioInvent International Enters into Agreement with Alligator Bioscience 12
BioInvent Partners With US Biotech Company 13
BioInvent Enters into Research Agreement with University of Southampton 14
BioInvent And CRT Enter Into Research Agreement With University Of Southampton 15
BioInvent And Cancer Research Technology Enter Into Co-Development Agreement With Queen Mary, University of London 16
Licensing Agreements 17
Pfizer Enters into Licensing Agreement with BioInvent International 17
BioInvent International Enters Into Licensing Agreement With Les Laboratoires Servier 18
BioInvent Enters into Licensing Agreement with University of Southampton and Cancer Research Technology 19
Equity Offering 20
BioInvent International Raises USD10.4 Million in Private Placement of Shares 20
BioInvent Raises USD19.2 Million in Rights Offering of Shares 22
BioInvent Raises USD5.1 Million in Private Placement of Shares 23
Bioinvent Raises USD9.4 Million in Right Issue of Shares 25
BioInvent Completes Rights Offering of Shares for USD7.4 Million 26
BioInvent Completes Private Placement of Shares for USD2.3 Million 27
BioInvent International Completes Rights Offering Of Common Stock For US$3.6 Million 28
BioInvent Raises USD15.5 Million in Rights Offering of Shares 29
BioInvent International AB – Key Competitors 30
BioInvent International AB – Key Employees 31
BioInvent International AB – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Jan 30, 2018: BioInvent Reports Net Sales Of SEK 45 Million In 2017 33
Jul 26, 2017: BioInvent Interim Report 1 January – 30 June 2017 34
May 17, 2017: BioInvent Interim Report 38
Corporate Communications 41
Apr 12, 2018: BioInvent recruits Martin Welschof as new CEO 41
Oct 24, 2017: The CEO of BioInvent Michael Oredsson will resign at the end of the year 42
Product News 43
Oct 16, 2018: BioInvent to Expand Pipeline With New Development Programs in Solid Cancer 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
BioInvent International AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioInvent International AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioInvent International AB, Deals By Therapy Area, 2012 to YTD 2018 8
BioInvent International AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioInvent and Transgene Enter into Co-Development Agreement 11
BioInvent International Enters into Agreement with Alligator Bioscience 12
BioInvent Partners With US Biotech Company 13
BioInvent Enters into Research Agreement with University of Southampton 14
BioInvent And CRT Enter Into Research Agreement With University Of Southampton 15
BioInvent And Cancer Research Technology Enter Into Co-Development Agreement With Queen Mary, University of London 16
Pfizer Enters into Licensing Agreement with BioInvent International 17
BioInvent International Enters Into Licensing Agreement With Les Laboratoires Servier 18
BioInvent Enters into Licensing Agreement with University of Southampton and Cancer Research Technology 19
BioInvent International Raises USD10.4 Million in Private Placement of Shares 20
BioInvent Raises USD19.2 Million in Rights Offering of Shares 22
BioInvent Raises USD5.1 Million in Private Placement of Shares 23
Bioinvent Raises USD9.4 Million in Right Issue of Shares 25
BioInvent Completes Rights Offering of Shares for USD7.4 Million 26
BioInvent Completes Private Placement of Shares for USD2.3 Million 27
BioInvent International Completes Rights Offering Of Common Stock For US$3.6 Million 28
BioInvent Raises USD15.5 Million in Rights Offering of Shares 29
BioInvent International AB, Key Competitors 30
BioInvent International AB, Key Employees 31
BioInvent International AB, Subsidiaries 32
List of Figures
BioInvent International AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioInvent International AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8